https://www.selleckchem.com/CDK.html
ildren in tandem. To evaluate the safety of maternal pertussis vaccination on pregnancy and birth outcomes. The study population comprised 1272 healthy nulliparous pregnant women who participated in Screening Tests to identify poor Outcomes in Pregnancy (STOP) study at two obstetric hospitals in South Australia between 2015 and 2018. Participants were followed prospectively, with vaccination (confirmed by medical records), extensive amounts of pregnancy and birth outcome data collected by research midwives. Adjusted relative risks (aRRs) and hazard
Like
Comment
Share
